Back to Search

NANG LOK ELLICK TSANG, M.D.

M.D.

Internal Medicine Physician

NPI: 1992873723Individual

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

CA A053928(CA)

CMS Specialties

PrimaryINTERNAL MEDICINE

Education

OTHER

Class of 1984

Research & Publications (20)

Detection of Epstein-Barr virus-derived latent membrane protein-1 gene in various head and neck cancers: is it specific for nasopharyngeal carcinoma?
PMID 12782821·Laryngoscope·2003
8-other
Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3.
PMID 19664746·Am J Hum Genet·2009
8-other
Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy-dye labeling combined with three-dimensional fractionation.
PMID 18668694·Proteomics·2008
7-preclinical
Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma.
PMID 18559600·Clin Cancer Res·2008
8-other
Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 53 patients and prognostic factors.
PMID 18368585·Acta Otolaryngol·2008
4-observational
Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
PMID 18206420·Oral Oncol·2008
8-other
Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
PMID 18534700·Radiother Oncol·2008
8-other
Gene expression and promoter polymorphisms of DNA methyltransferase 3B in nasopharyngeal carcinomas in Taiwanese people: a case-control study.
PMID 18097598·Oncol Rep·2008
8-other
Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes.
PMID 18980993·Clin Cancer Res·2008
8-other
MCP-1 Promoter Polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment.
PMID 17975143·Clin Cancer Res·2007
8-other
Polymorphism of C-terminal activation region 2 of Epstein-Barr virus latent membrane protein 1 in predicting distant failure and post-metastatic survival in patients with nasopharyngeal carcinoma.
PMID 17103409·Head Neck·2007
8-other
Practice tips. Smear tactics: a more comfortable Papanicolaou test.
PMID 17872746·Can Fam Physician·2007
8-other
Factors that influence length of stay for in-patient gynaecology surgery: is the Case Mix Group (CMG) or type of procedure more important?
PMID 16643718·J Obstet Gynaecol Can·2006
8-other
Treatment of squamous cell carcinoma of the retromolar trigone.
PMID 16735888·Laryngoscope·2006
8-other
The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma.
PMID 16585856·Laryngoscope·2006
4-observational
Thymic lymphoepitheliomalike carcinoma in children: clinicopathologic features and molecular analysis.
PMID 17164646·J Pediatr Hematol Oncol·2006
5-case
Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model.
PMID 16035111·Proteomics·2005
7-preclinical
Lhermitte's sign among nasopharyngeal cancer patients after radiotherapy.
PMID 15627248·Head Neck·2005
8-other
The time frame of Epstein-Barr virus latent membrane protein-1 gene to disappear in nasopharyngeal swabs after initiation of primary radiotherapy is an independently significant prognostic factor predicting local control for patients with nasopharyngeal carcinoma.
PMID 16169672·Int J Radiat Oncol Biol Phys·2005
8-other
Molecular diagnosis of nasopharyngeal carcinoma: detecting LMP-1 and EBNA by nasopharyngeal swab.
PMID 15523443·Otolaryngol Head Neck Surg·2004
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3085 24TH ST, STE 203
SAN FRANCISCO, CA 94110

Location

Practice Location

3085 24TH ST, SAN FRANCISCO, CA
(415) 648-5900

Quick Facts

NPI
1992873723
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Years in Practice
42
Publications
20

Are you this provider?

Claim Your Profile